Oncodesign Precision Medicine
1 clinical trials · Sponsor
◉ Watch Oncodesign Precision Medicine
| Record | Firm | Date |
|---|---|---|
| Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1 (NCT07040436) | Oncodesign Precision Medicine | 2025-09-01 |
Track Oncodesign Precision Medicine automatically
Every clearance here is in the API, with alerts when new ones post.